𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial

✍ Scribed by Lorenzo Cohen; Carl de Moor; Robert J. Amato

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
100 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Association between depression and survi
Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial
✍ Kathryn E. Lazure; William M. Lydiatt; David Denman; William J. Burke πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 1 views

## Abstract ## __Background.__ To determine if depression portends a worse prognosis in patients with head and neck cancer, we conducted a retrospective chart analysis of subjects who participated in a randomized placebo‐controlled trial of citalopram for the prevention of depression during head a

Phase I trial of paclitaxel, carboplatin
Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer
✍ John D. Hainsworth; Howard A. Burris III; Lisa H. Morrissey; F. Anthony Greco πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 3 views

## Background: Topotecan is a new antineoplastic agent with a broad spectrum of activity. the purpose of this phase i trial was to define the maximum tolerated dose of topotecan when added to the widely used combination of paclitaxel and carboplatin. ## Methods: Patients with advanced cancer that